HOME

THE FIRST LINE OF VERSATILE, PERSONALISED

ANTIMICROBIAL, ANTIVIRAL
AND ANTI-INFLAMMATORY COATINGS

FOR MEDICAL DEVICES

FOR DAILY USE*

*Shown to inactivate SARS-CoV-2 (Covid-19)

Hospital Acquired Infections
0 %
of the cases are related with medical devices.

SPARTHA Medical has developed multifunctional coatings that can prevent
device related infection and diminish inflammation

without affecting the function of the  medical device.
We offer customised coating development for producers with specific properties optimized for the target microenvironment
We develop a « coating kit » to be utilized directly in hospitals with respect to the patient immunoprofile
We develop a biocompatible spray for general/daily use

OUR STORY

SPARTHA Medical is a spin-off from INSERM UMR1121
a public research institute with more than 20 years of experience in development of coating.

SPARTHA Medical ’s core technologies
are based patented inventions coming from two European projects (IMMODGEL and PANBioRA) that started in 2013.

OUR TEAM

Our Multidisciplinary Team brings together Know-How and Expertise in :
| Medical Device Design and Development
| Coating Technologies
| BioTechnology Business Development
| Production and Regulatory Affairs

OUR SUPPORTS

SPARTHA Medical has a strong support from :
| University of Strasbourg | SATT Conectus | INSERM and our partners in the ongoing | PANBioRa project.
We are incubated in | SEMIA and financially supported by | Grand Est region (Start-up support) and | French Public Bank of Investment (BPI, i-Lab 2019)

PLEASE DO NOT HESITATE TO CONTACT US IF YOU REQUIRE ANY FURTHER INFORMATION

TAKE A LOOK AT OUR LATEST NEWS

SPARTHA Medical is a laureate of the EIC Accelerator

The EIC Accelerator is the European Innovation Council’s (EIC) programme for SMEs. Launched by the European Commission in September 2019 in its pilot phase ahead of Horizon Europe. The EIC aims to stimulate Europe’s economic growth by enabling visionary and … Read More

Featured Post

SPARTHA Medical raised €1.4M

SPARTHA MEDICAL COMPLETES ITS FIRST ROUND OF FUNDING TO DEVELOP ITS CUSTOMISED COATINGS OFFER (€1.4M) Strasbourg, FRANCE, 8 Decembre 2021. SPARTHA Medical, a French MedTech company specialising in the development of multifunctional antimicrobial, antiviral and anti-inflammatory coatings, is pleased to … Read More

Featured Post

SPARTHA Medical owns a research and development approval (CIR)

SPARTHA Medical has been granted for CIR accreditation SPARTHA Medical is pleased to announce the company has been granted for CIR accreditation for research and development (R&D) after scientific and technical expertise. • What does it mean ? The Research Tax Credit … Read More

Featured Post